¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"generalized obstructive lung disease"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
  • Monge disease
    ¸ùÇ캴
  • motor neuron disease
    ¿îµ¿½Å°æ¼¼Æ÷º´, ¿îµ¿½Å°æ¿øº´
  • mountain disease
    °í»êº´
  • moyamoya disease
    ¸ð¾ß¸ð¾ßº´
  • muscle disease
    ±ÙÀ°º´
  • mycobacterial disease
    Ç×»ê±Õº´, ¹ÌÄÚ¹ÚÅ׸®¾Æº´
  • mycoplasma disease
    ¹ÌÄÚÇö󽺸¶º´
  • maple syrup urine disease
    ´Üdz½Ã·´´¢º´
  • marble bone disease
    ´ë¸®¼®º´, °ñÈ­¼®º´
  • Marburg disease
    ¸¶¸£ºÎ¸£Å©º´
  • Marburg virus disease
    ¸¶¸£ºÎ¸£Å©¹ÙÀÌ·¯½ºº´
  • Marchiafava-Bignami disease
    ¸¶¸£Å°¾ÆÆÄ¹Ù-ºñ³Ä¹Ìº´
  • mast cell disease
    ºñ¸¸¼¼Æ÷º´
  • McArdle¡¯s disease
    ¸Æ¾Æµéº´
  • medullary cystic disease
    ¼ÓÁú³¶º´, ¼öÁú³¶¼ºº´
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
  • notifiable disease
    ½Å°í´ë»óÁúº´
  • nutritional disease
    ¿µ¾çº´
  • nutritional deficiency disease
    ¿µ¾ç°áÇ̺´
  • obliterative arterial disease
    Æó»öµ¿¸Æº´
  • occlusive cerebrovascular disease
    Æó¼â³úÇ÷°üÁúȯ
  • occupational disease
    Á÷¾÷º´
  • occupational dental disease
    Á÷¾÷Ä¡°úº´
  • oculoglandular disease
    ´«»ùº´
  • oral disease
    ÀÔº´, ±¸°­Áúȯ
  • organic disease
    ±âÁúº´
  • pandemic disease
    ¹üÀ¯Çິ
  • panzootic disease
    µ¿¹°¹üÀ¯Çິ
  • parasitic disease
    ±â»ýÃæº´
  • paroxysmal disease
    ¹ßÀÛº´
  • pelvic inflammatory disease
    °ñ¹Ý³»°¨¿°
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
  • addisons disease
    ¾Öµð½¼º´(¡­Ü»)
  • adipose tissue disease
    Áö¹æÁ¶Á÷Áúȯ.
  • adjuvant disease
    ¾ÖÁÖ¹øÆ®º´.
  • adult disease
    ¼ºÀκ´(à÷ìÑÜ»).
  • african sleeping disease
    ¾ÆÇÁ¸®Ä« ¼ö¸éº´(¡­â²ØùÜ»)
  • air borne disease
    °ø±â¸Å°³Áúȯ.
  • air pilots disease
    ºñÇàÁ¶Á¾»çº´.
  • air space disease
    °ø±â °ø°£ Áúȯ
  • aircraft disease
    Ç×°øº´.
  • allergic disease
    ¾Ë·¹¸£±â¼º Áúȯ, ¾Ë·¹¸£±âº´
  • allergic disease
    ¾Ë·¹¸£±â(¼º) Áúȯ
  • allergic respiratory disease
    ¾Ë·¹¸£±â¼º È£Èí±âº´
  • allergic skin disease
    ¾Ë·¹¸£±â(¼º)ÇǺΠÁúȯ
  • allergic skin disease
    ¾Ë·¹¸£±â[¼º] ÇǺκ´
  • alpha chain disease
    ¾ËÆÄ¼âº´(¡­áðÜ»).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
  • adult disease
    ¼ºÀκ´(à÷ìÑÜ»).
  • african sleeping disease
    ¾ÆÇÁ¸®Ä« ¼ö¸éº´(¡­â²ØùÜ»)
  • air borne disease
    °ø±â¸Å°³Áúȯ.
  • air pilots disease
    ºñÇàÁ¶Á¾»çº´.
  • air space disease
    °ø±â °ø°£ Áúȯ
  • aircraft disease
    Ç×°øº´.
  • albers-sch berg disease
    ¾Ëº£¸£½º-½¨º£¸£Å© º´(¡­Ü»)
  • albers-schonberg disease
    ¾Ëº£¸£½º-½¨º£¸£Å©º´(¡­Ü»)
  • alcoholic liver disease
    ¾ËÄڿüº °£Áúȯ(¡­àõ ÊÜòðü´)
  • alexanders disease
    ¾Ë·º»ê´õ º´(¡­Ü»)
  • alkali disease =alkalosis
    ¾ËÄ®¸®º´ ¾ËÄ®¸®(Ç÷)Áõ .
  • allergic disease
    ¾Ë·¹¸£±â¼º Áúȯ, ¾Ë·¹¸£±âº´
  • allergic disease
    ¾Ë·¹¸£±â(¼º) Áúȯ
  • allergic respiratory disease
    ¾Ë·¹¸£±â¼º È£Èí±âº´
  • allergic skin disease
    ¾Ë·¹¸£±â(¼º)ÇǺΠÁúȯ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 19
AILD alveolar interstitial lung disease; angioimmunoblastic lymphadenopathy
CDILD chronic diffuse interstitial lung disease
CHLD chronic hypoxic lung disease
CNSLD chronic nonspecific lung disease
FLD fibrotic lung disease
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 19
EEV end expiratory lung volume
FLM fetal lung maturity
HEL human embryonic lung fibroblast
ILV instantaneous lung volume
IPL isolate perfused lung
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • saccharine disease
    »çÄ«¸° º´
    ½ÄÀ̼º ¼¶À¯¿Í ´Ü¹éÁúÀ» Á¦°ÅÇϰí Á¤Á¦ÇÑ ÇÔ¼öź¼Ò ½Ä»ç¸¦ °úµµÇÏ°Ô ¼·ÃëÇÏ¿© »ý±â´Â Áúº´¿¡ ´ëÇÏ¿© Á¦Ã¢µÈ ¿ë¾îÀÌ´Ù. À̰Ϳ¡´Â ´ç´¢º´, ½ÉÇ÷°ü Áúȯ, º¯ºñ, ºñ¸¸Áõ ¹× ¼ÒÈ­¼º ±Ë¾ç µîÀÌ Æ÷ÇԵȴÙ.
  • salivary gland disease
    Ÿ¾×¼± Áúȯ
  • Saunders' disease
    »ç¿î´õÁî º´
    Á¥¸ÔÀÌ¿¡°Ô °ú·®ÀÇ Åº¼öÈ­¹° À½½ÄÀ» ÁÖ¾úÀ» ¶§ ÀϾ´Â ¼ÒÈ­ Àå¾Ö¿¡¼­ º¼ ¼ö ÀÖ´Â À§ÇèÇÑ Áõ»ó. ±¸Åä, ³ú Áõ»ó, ¼øÈ¯ Àå¾Ö°¡ Ư¡ÀÌ´Ù.
  • Schamberg's disease ¸¸¼º, ¹«Áõ»ó¼º ÇǺΠÁúȯÀ¸·Î »çÃá±â¿Í Àå³â±âÀÇ ³²ÀÚ¿¡°Ô ¹ß»ýÇÑ´Ù. ¾Õ Á¤°­ÀÌ, ¹ß¸ñ, ¹ß, ¹ß°¡¶ô µî¿¡ ±¹ÇÑÇÏ¿© ³ªÅ¸³ª´Â µî»ö ¶Ç´Â ´ãȲ °¥»öÀÇ °¡ÀåÀÚ¸®¿¡ Àû»öÁ¡À» °¡Áø ¹Ý»ó ¹ßÁøÀ» Ư¡À¸·Î ÇÑ´Ù.

    Schanz's syndrome

    ¼¢Áî ÁõÈıº
    ÇǷΰ¨, ôÃß µ¹±âÀÇ ¾ÐÅë, º¹¿ÍÀ§¿¡¼­ÀÇ µ¿Åë, ôÃß ¸¸°î µî, ôÃßÀÇ ¼è¾àÀ» ³ªÅ¸³»´Â ÀÏ·ÃÀÇ ÁõÈÄ.
  • Schilder's disease
    ½¯´õº´
    1. 1912³â¿¡ ±âÀçÇÑ ¼Ò¾Æ ¹× ÀþÀºÀÌ¿¡°Ô ÀϾ´Â ¿øÀÎ ºÒ¸íÀÇ µå¹® ÁúȯÀ¸·Î¼­, ÁÖ·Î ´ë³ú ¹Ý±¸¸¦ ħ¹üÇϸç, Á¶±â¿¡ Àå´Ô, ±Í¸Ó°Å¸®, °¨°¢Àå¿¡ µîÀÇ Áõ»óÀÌ ³ªÅ¸³­´Ù. 2. ¹éÁú³úÁõÀÇ ¾Æ±Þ¼º ¶Ç´Â ¸¸¼ºÇüÀ¸·Î ¼Ò¾Æ ¹× û³â¿¡°Ô¼­ º¼ ¼ö ÀÖ´Ù. ÀÓ»óÁõ»óÀ¸·Î´Â ½Ç¸í, ³­Ã», ¾çÃø¼º °æ·Ã, ÁøÇ༺ Á¤½ÅȲÆó µîÀÌ ³ªÅ¸³­´Ù. ´ë³ú ¹éÁúÀÇ ±¤¹üÇÑ ÆÄ±«°¡ ÀÖ°í, °øµ¿ÀÌ Çü¼ºµÈ´Ù. º¸Åë »ê¹ßÀûÀ¸·Î ¹ß»ýÇϳª °¡Á·¼ºÀÇ º´ÇüÀ¸·Îµµ º¸°íµÇ¾î ÀÖ´Ù.
  • Schmorl's disease
    ½¬¸ð¸¦ º´
    1. ÀÎÁ¢ÇÑ º¹Ã¼ºÎ¿¡ÀÇ ¼öÇÙ Å»Ãâ.
  • Scholz's disease
    ¼ñÃ÷ º´
    ¹éÁú ³úÁõÀÇ °¡Á· ¼ºÇüÀ¸·Î ¹Ý¼º ¿­¼º À¯Àü. 8¼¼ °æ¿¡ ½ÃÀÛÇÏ¿© ³ú¹éÁúÀÇ Å»¼öÈ­, °¨°¢¼º ½Ç¾îÁõ, ÇÇÁú¼º ½Ç¸í, ³­Ã», Çã¾à, »çÁöÀÇ °æ·Ã, ¿ÏÀü ¸¶ºñ, Ä¡¸Å°¡ Ư¡ÀÌ´Ù.
  • seasonal disease
    °èÀýº´
    °èÀý¿¡ µû¶ó ¹ß»ýÇÏ´Â º´ÀÇ ÃÑĪ. °èÀýÀÇ º¯È­°¡ º´À» ÀÏÀ¸Å²´Ù´Â °ÍÀ» óÀ½ ±â·ÏÇÑ »ç¶÷Àº È÷Æ÷Å©¶óÅ×½º¿´´Âµ¥, À̸¦ ±Ù´ë ÀÇÇÐÀûÀÎ ¹æ¹ýÀ¸·Î ¿¬±¸ÇÑ »ç¶÷Àº µ¶ÀÏÀÇ µ¥ ·ç´õ¿´´Ù. ±×´Â ±â´Ü ±³Ã¼ ¶§ÀÇ Àü¼± Åë°ú¿Í °¢Á¾ Áúº´°úÀÇ °ü·ÃÀ» Åë°èÇÐÀûÀ¸·Î Á¶»çÇÏ¿´À¸¸ç, ƯÈ÷ ºÏ¹Ý±¸ÀÇ °èÀý°ú °ü°è°¡ ±íÀº Áúº´ÀÇ ¿¬°£ºÐÆ÷Ç¥´Â °èÀýº´ ͏°´õÀÇ ½ÃÃʷμ­ À¯¸íÇÏ´Ù. ¾î¶² º´À» °èÀýº´À¸·Î Ãë±ÞÇϱâ À§Çؼ­´Â, ±× º´ÀÇ À¯¹ßÀÎÀÚ ¶Ç´Â ±× º´À» Àü¿°½ÃŰ´Â À§»ý °ïÃæ µîÀÌ °èÀýÀûÀ¸·Î º¯µ¿Çϰí ÀÖ´Ù´Â Á¡, ¶Ç´Â Àΰ£ ÀÚü°¡ ±× º´¿¡ °É¸®±â ½¬¿î »óŰ¡ °èÀý¿¡ ÀÇÇØ¼­ Á¿ìµÈ´Ù´Â Á¡ µîÀÌ ¾î¶»°Ô ¼­·Î ¾ôÇô ÀÖ´ÂÁö Á¶»çÇÒ Çʿ䰡 ÀÖ´Ù. Çѱ¹ÀÇ °æ¿ì, ¾î¸°ÀÌÀÇ ¼ÒÈ­±â º´À̳ª ´Üµ¶ µîÀÇ ÇǺΠÁúȯÀº ¿©¸§¿¡ ¸¹°í, °Ü¿ï¿¡¼­ º½¿¡ À̸£·¯ Â÷°í ¸Þ¸¶¸¥ ±âÈÄÀÏ ¶§¿¡´Â °¨±â, Æó·Å, ±Þ¼º ±â°üÁö¿° µîÀÌ ¸¹´Ù.
  • self limited disease
    ÀÚ±â ÇÑÁ¤¼º Áúȯ
    Áúȯ ÀÚüÀÇ ¼ºÁú ¶§¹®¿¡ ÀÏÁ¤Çϰí ÇÑÁ¤µÈ °æ°í¸¦ ÃëÇÏ´Â Áúȯ.
  • sexually transmitted disease
    ¼º Àü¿°¼º Áúȯ
    Åë»óÀûÀÎ ¼º±³¿¡ ÀÇÇÑ ¼ºº´À» Æ÷ÇÔÇÏ¿©, ¼º±³´Â ¾Æ´ÏÁö¸¸ À¯»çÇÑ ¼º ÇàÀ§·Î °¨¿°µÇ´Â ¸ðµç Áúȯ. ¼º¿¡ ´ëÇÑ »çȸ °ü½ÀÀº Áö³­ ¼ö ½Ê ³â¿¡ °ÉÃÄ ¸¹ÀÌ º¯È­ÇÏ¿´À¸¸ç, 1970³â´ë¿¡ À̸£·¯ ¼º ÇàÀ§ÀÇ ´Ù¾ç¼ºÀÌ µÎµå·¯Áö°Ô ³ªÅ¸³µ´Ù. Áï, À̼º°£ÀÇ ¼º±³»Ó¸¸ ¾Æ´Ï¶ó µ¿¼º°£¿¡ ÇàÇÏ¿©Áö´Â ¿©·¯ ÇüÅÂÀÇ ¼º ÇàÀ§, ¿©·¯ »ó´ëÀÚ¿ÍÀÇ ¼º °ü°è, ´Ù¾çÇÑ ¼º ±â±³ ¹× ±¸°­ ¼º±â ¼º ÇàÀ§ µî ´Ù¾çÇØÁ³À¸¸ç, ÀÌ¿¡ µû¶ó °¨¿°ÀÇ Á¾·ùµµ Áõ°¡ÇÏ¿´´Ù. ¶ÇÇÑ °¨¿° °æ·Îµµ Åë»óÀû ¼º±³ ¿Ü¿¡ ±¸°­ ¹× ¼º±â¿¡ÀÇ ÀÔ¸ÂÃã¿¡ ÀÇÇÑ °æ±¸ °¨¿°, µ¿¼º¾Ö ³²¼º°£¿¡ ÇàÇÏ¿©Áö´Â Ç×¹® ¼º±³ ¹× ¿©·¯ »ç¶÷ÀÌ ¾î¿ï·Á ºÒ°áÇÏ°Ô À̺ÎÀÚ¸®¸¦ °°ÀÌ »ç¿ëÇÏ´Â µ¥¼­ ¿À´Â ±â»ýÃæ °¨¿° µî ¿©·¯ °¡Áö°¡ ÀÖ´Ù. ¼º Àü¿°¼º ÁúȯÀ» ÀÏÀ¸Å°´Â º´¿øÃ¼µµ ´Ù¾çÇÏ¿©, ´ëº°ÇØ º¸¸é, ¼¼±Õ, ¹ÙÀÌ·¯½º, Ŭ¶ó¹Ìµð¾Æ Æ®¶óÄÚ¸¶Æ¼½º
  • silo-filler's disease
    »çÀÏ·Î Ãæ¸¸ °¡½ºº´
    ¶§¶§·Î ±Þ¼º Æó ºÎÁ¾À» ¼ö¹ÝÇÏ´Â ÆóÀÇ ¿°ÁõÀ¸·Î, »çÀϷο¡ ¸ðÀÎ Àڱؼº °¡½ºÀÇ ÈíÀÔÀÌ ¿øÀÎÀÌ´Ù.
  • Simmonds' disease
    ½Ã¸óµå º´, ½Ã¸óÁ
    1. ÇϼöüÀÇ À§ÃàÀ¸·Î ÀÎÇØ ±ØµµÀÇ ¼è¾à, ¼Ò¸ð, ¹× Á¤½Å Àå¾Ö¸¦ À¯¹ßÇϰí, Á¶·Î, Å»¸ð, ¼º¿å °¨Åð, ±âÃÊ ´ë»ç ÀúÇÏ µîÀ» Ư¡À¸·Î Çϴµ¥ ÁÖ·Î ¿©ÀÚ¿¡¼­ º¼ ¼ö ÀÖ´Ù. 2. somatotro
  • smith strang disease : ¸ÞŸÀÌ¿À´Ñ Èí¼ö Àå¾Ö¿¡ ÀÇÇÑ °ÍÀ¸·Î »ó¿°»öü¼º ¿­¼º ÇüÁú·Î À¯ÀüµÈ´Ù. È© °ÇÁ¶¼Ò³»ÀÇ ³¿»õ¿Í ºñ½ÁÇÑ Æ¯À¯ÇÑ ³¿»õ¸¦ ³»¸ç, À̰ÍÀº Èí¼öµÇÁö ¾ÊÀº ¸ÞŸÀÌ¿À´Ñ¿¡ ´ëÇÑ ¼¼±ÕÀÇ ÀÛ¿ë¿¡ ÀÇÇÏ¿© Á¶¼ºµÇ´Â ¾ËÆÄ ÇÏÀ̵å·Ï½Ã ³«»êÀÌ ¿øÀÎÀÌ´Ù.

    Smith's dis

    ½º¹Ì½º º´
  • Soederland's disease
    Á¦µ¥¸¦¶õµå º´
    »ïÃ⼺ ¹æ±¤¿°À» ¸»Çϴµ¥, ¹«±Õ ³ó´¢º´À̶ó°íµµ ÇÑ´Ù.
  • spirochetal disease
    ½ºÇÇ·ÎÇìŸ Áúȯ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
caffey disease <radiology> Infantile cortical hyperostosis, aetiology unknown, onset before 5 months of age, hyperostosis and periosteal reaction, mandible (80-95%), clavicles, ribs, long bones (DIAPHYSES often asymmetric) Differential diagnosis: if metaphyses involved, consider battery (child abuse)
(12 Dec 1998)
Caffey's disease Neonatal subperiosteal bone formation over many bones, especially the mandible and clavicles and the shafts of long bones; it follows fever, usually appearing before 6 months of age and disappearing during childhood.
Synonym: Caffey's disease, Caffey's syndrome, Caffey-Silverman syndrome.
(05 Mar 2000)
caisson disease See: decompression sickness
Origin: Fr. Caisson (fr. Caisse, a chest) a water-tight box or cylinder containing air under high pressure used in sinking structural pilings underwater
(05 Mar 2000)
calcium pyrophosphate deposition disease <radiology> Manifestations can occur singly or in any combination, pseudogout, acute crystal-induced synovitis with clinical symptoms analogous to gout, arthropathy, beaklike osteophytes of 2nd, 3rd metacarpal heads, subchondral cysts (especially carpal bones), unusual distribution of disease (radiocarpal/ulnar joint, patellofemoral joint), SLAC - scapholunate advanced collapse, chondrocalcinosis, triangular fibrocartilage, symphysis pubis, menisci of knee, annulus fibrosus of intervertebral disk
(12 Dec 1998)
Calve-Perthes disease perthes disease
camurati-engelmann disease <radiology> Sclerosing diaphyseal dysplasia, does not involve metaphysis, epiphysis, or bone marrow cavity Cf: Albers-Schoenberg disease
(12 Dec 1998)
canavan disease Spongy degeneration of cerebral white matter, a rare autosomal recessive form of leukodystrophy. It is characterised by early onset, widespread demyelination and vacuolation of the white matter that gives rise to a spongy appearance, severe mental retardation, megalocephaly, atony of the neck muscles, spasticity of the extremities, and blindness. Death occurs at about 18 months of age.
(12 Dec 1998)
Canavan's disease Autosomal recessive degenerative disease of infancy; mostly in Jewish infants; onset typically within first 3-4 months of birth, consisting of blindness, psychomotor regression, enlarged head, optic atrophy, hypotonia, spasticity, increased N-acetylaspartic acid urinary excretion. MRI shows enlarged brain, decreased attenuation of cerebral and cerebellar white matter, and normal ventricles. Pathologically, there is increased brain volume and weight, and spongy degeneration in the subcortical white matter.
See: leukodystrophy.
Synonym: Canavan's sclerosis, Canavan-van Bogaert-Bertrand disease, spongy degeneration of infancy.
(05 Mar 2000)
Canavan-van Bogaert-Bertrand disease Autosomal recessive degenerative disease of infancy; mostly in Jewish infants; onset typically within first 3-4 months of birth, consisting of blindness, psychomotor regression, enlarged head, optic atrophy, hypotonia, spasticity, increased N-acetylaspartic acid urinary excretion. MRI shows enlarged brain, decreased attenuation of cerebral and cerebellar white matter, and normal ventricles. Pathologically, there is increased brain volume and weight, and spongy degeneration in the subcortical white matter.
See: leukodystrophy.
Synonym: Canavan's sclerosis, Canavan-van Bogaert-Bertrand disease, spongy degeneration of infancy.
(05 Mar 2000)
cancer, hodgkin's disease A type of lymphoma (cancer of the lymphatic system). The most common symptom of Hodgkin's disease is a painless swelling in the lymph nodes in the neck, underarm, or groin. Hodgkin's disease is diagnosed when abnormal tissue is detected by a pathologist after a biopsy of an enlarged lymph node. Treatment usually includes radiation therapy or chemotherapy. Regular follow-up examinations are important after treatment for Hodgkin's disease. Patients treated for Hodgkin's disease have an increased risk of developing other types of cancer later in life, especially leukaemia.
(12 Dec 1998)
canine parvovirus disease An acute disease of dogs with a variable mortality rate caused by the canine parvovirus; seen in three distinct clinical forms; a generalised neonatal disease, a severe nonsuppurative myocarditis, and a frequently fatal enteritis.
(05 Mar 2000)
carcinoid heart disease Cardiac manifestation of malignant carcinoid syndrome. It is a unique form of fibrosis involving the endocardium, primarily of the right heart. The fibrous deposits tend to cause constriction of the tricuspid and pulmonary valves.
(12 Dec 1998)
caroli disease <radiology> Communicating, cavernous ectasia of the intrahepatic bile ducts, rare, autosomal recessive, usually detected in young adults, no cirrhosis or portal hypertension, predisposed to calculus formation, benign course, but.. Recurrent cholangitis most likely to be liver abscesses most likely to be death, associated with medullary sponge kidney (renal tubular ectasia) in 80%
(12 Dec 1998)
caroli's disease Congenital cystic dilatation of the intrahepatic bile ducts. It consists of 2 types: simple, with bile duct dilatation or ectasia alone, and complex, with associated extensive hepatic fibrosis and portal hypertension. Benign renal tubular ectasia is associated with both types.
(12 Dec 1998)
rabbit haemorrhagic disease A highly infectious disease of rabbits, caused by a calicivirus and characterised by haemorrhagic lesions, particularly affecting the lungs and liver; since it was first identified in China in 1984, it has been reported from Korea, it has spread through Europe, and it has reached North Africa and Mexico.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 19
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 19
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 19
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 19
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 19
ÅëÇÕ°Ë»ö ¿Ï·á